AI Visibility Scorecard
ULTOMIRIS® (ravulizumab-cwvz) NMOSD Patient Website
understandingyourcondition.com · Healthcare
At 3/10, ULTOMIRIS® (ravulizumab-cwvz) NMOSD Patient Website is close to invisible in AI search today. Most assistants will not cite it when asked about your category - fixable, and the signals below show exactly where to start.
Monitoring for AI engine activity
In the Engagemii AEO index
#879,977 of 923,537 in Healthcare for AI visibility
3
AEO Visibility
iNear-invisible · 3/10
0
Muse Index Score
iAI agent readiness
Not agent-ready · 0/100
0
AI Adoption
iNone detected · 0/100
About ULTOMIRIS® (ravulizumab-cwvz) NMOSD Patient Website
from our crawl and measurement
"Learn about ULTOMIRIS, a treatment for adults with anti-AQP4 antibody-positive NMOSD. Please see full Prescribing Information, including Boxed WARNING." That is how ULTOMIRIS® (ravulizumab-cwvz) NMOSD Patient Website introduces itself. To AI engines like ChatGPT and Perplexity, though, it is barely visible: it scores 3.0 out of 10.
The site gets some of it right: it has substantial page content. What holds it back is what is absent, including structured data describing the business, an llms.txt file, a sitemap.
The 6 signals AI reads
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Good
Clear headings and answer-style content.
Entity Clarity
Fair
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Weak
Experience, Expertise, Authority, Trust markers.
Technical AEO
Good
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Fair
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
Weak
No inbound links found yet.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 3/10, ULTOMIRIS® (ravulizumab-cwvz) NMOSD Patient Website is crawlable but under-signaled - fixable, and the signals above are where to start.
Is this your brand?
The exact fixes for ULTOMIRIS® (ravulizumab-cwvz) NMOSD Patient Website
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
Why your brand doesn't show up in ChatGPT answers (and how to fix it)
ChatGPT doesn't crawl the web like Google does. When someone asks Claude about the best project management tools, the model isn't searching your website in real-time. It's pulling from training data that stopped months or years ago.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for ULTOMIRIS® (ravulizumab-cwvz) NMOSD Patient Website.
Source & Attribution
Scored by Engagemii on July 31, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/understandingyourcondition
Cite this score: Engagemii (2026). "AEO Score for ULTOMIRIS® (ravulizumab-cwvz) NMOSD Patient Website." Retrieved from https://engagemii.com/aeo/brands/understandingyourcondition
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform